Treatment effect of topical fluconazole nanoparticles on Tinea versicolor

Evaluation of Fluconazole-NLC nano emulgel (0.5%) effect on Tinea versicolor in comparison with clotrimazole cream

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120707010203N10

Enrollment

Registered

2021-01-03

Start date

2016-04-20

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinea versicolor. Pityriasis versicolor

Interventions

Intervention 1: Intervention group: Fluconazole nanoparticles (NLC) emulgel 0.5%, will be prepared in faculty of pharmacy and will be formulated as nano-emulgel 0.5%. The preparations will be packaged

Eligibility

Sex/Gender

All

Age

5 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical feature of Tinea versicolor Positive Smear test

Exclusion criteria

Exclusion criteria: Liver disease Nephrotic disorders Diabetes Malignant disease Pregnancy Breast feeding anti-fungal treatment in recent one months Sore or damage in infected area

Design outcomes

Primary

Measure	Time frame
Skin lesion area. Timepoint: At the beginning of study (time zero) and 2, 4 and 8 weeks after treatment. Method of measurement: Clinical evaluation and smear test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Saeedi

Mazandaran University of Medical Sciences

msaeedi@mazums.ac.ir+98 11 3354 3084

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026